NeuroSense Therapeutics Ltd. Gains 48.81%

Mon, Jun 27, 2022 at 08:30 PM
NeuroSense Therapeutics Ltd. Gains 48.81%

NeuroSense Therapeutics Ltd. (NRSN:NASDAQ) shot up at $2.5, a gain of 48.8%. On Mon, Jun 27, 2022, NRSN:NASDAQ touched a New 2-Week High of $2.5. The stock got featured on our News Catalysts scanner on Mon, Jun 27, 2022 at 08:49 AM in the 'EARNINGS' category. From Tue, Jun 14, 2022, the stock recorded 75.00% Up Days and 66.67% Green Days

The stock spiked on Mon, Jun 27, 2022 at $3.3 with a volume of 99M+.

About NeuroSense Therapeutics Ltd. (NRSN:NASDAQ)

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these...

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.